Target intelligence / Profile preview

Linear Ubiquitin Chain Assembly Complex (LUBAC) (LUBAC)

Target
LUBAC
Molecular classification
Enzyme, E3 ubiquitin ligase complex, Protein complex
01

Overview

The Linear Ubiquitin Chain Assembly Complex (LUBAC) is a multi-subunit E3 ubiquitin ligase composed of HOIP (RNF31), HOIL-1L (RBCK1), and SHARPIN [1]. It is uniquely characterized by its ability to catalyze the formation of M1-linked (linear) ubiquitin chains, which are critical regulators of the canonical NF-kappaB signaling pathway [2]. By attaching linear ubiquitin chains to substrates such as NEMO (IKK-gamma), LUBAC facilitates the recruitment and activation of the IKK complex, leading to the transcription of genes involved in inflammation, immune response, and cell survival [3]. Dysregulation of LUBAC is implicated in several pathologies, including activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL), where it promotes oncogenic signaling, and various autoinflammatory and immunodeficiency syndromes [4, 5]. Because of its central role in pro-survival signaling, LUBAC is an attractive therapeutic target for cancer and chronic inflammatory diseases [6]. Small-molecule inhibitors, such as HOIPINs, are currently being developed to selectively block the catalytic activity of the HOIP subunit to dampen pathological NF-kappaB activation [7]. Sources: [1] Kirisako et al. (2006) EMBO J; [2] Tokunaga et al. (2009) Nature; [3] Gerlach et al. (2011) Nature; [4] Yang et al. (2014) Cancer Cell; [5] Boisson et al. (2012) J Exp Med; [6] Kloetgen et al. (2020) Commun Biol; [7] Katsuya et al. (2018) Biochem J.

Other names
HOIP-HOIL-1L-SHARPIN complexM1-linked ubiquitin ligase complexRNF31-RBCK1-SHARPIN complexLinear ubiquitin signaling pathway
02

Mechanism of action

Inhibition of the HOIP subunit's catalytic RBR domain to prevent the assembly of M1-linked ubiquitin chains, thereby blocking the activation of the IKK complex and downstream NF-kappaB signaling.

03

Biological functions

Signal transductionImmune responseApoptosis regulationInflammationNF-kappaB activationNecroptosis regulation
04

Disease associations

CancerInflammationAutoimmune diseaseInfectionImmunodeficiencyDiffuse large B-cell lymphoma
05

Safety considerations

Increased sensitivity to TNF-induced cell death (apoptosis and necroptosis)Potential for primary immunodeficiencyRisk of systemic inflammatory response syndromeImpaired B-cell and T-cell development
06

Interacting drugs

HOIPIN-1

4 more in the full profile.

07

Biomarkers

M1-linked ubiquitin chain levelsRNF31 protein expressionIkappaB-alpha phosphorylation levelsNEMO ubiquitination status

Beyond the preview

Go deeper on Linear Ubiquitin Chain Assembly Complex (LUBAC) (LUBAC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Linear Ubiquitin Chain Assembly Complex (LUBAC) (LUBAC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call